| Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7) | Lancet Infectious Diseases, The | 2019 | 137 |
| A genome-wide transcriptomic analysis of protein-coding genes in human blood cells | Science | 2019 | 131 |
| Challenges for mesenchymal stromal cell therapies | Science Translational Medicine | 2019 | 83 |
| A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function | Journal of Experimental Medicine | 2019 | 71 |
| Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis | Blood Advances | 2019 | 71 |
| Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma | Leukemia | 2019 | 70 |
| Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials | Clinical Infectious Diseases | 2019 | 69 |
| Subcutaneous delivery of daratumumab in relapsed or refractory multiple myeloma | Blood | 2019 | 59 |
| Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma | PLoS ONE | 2019 | 55 |
| Targeting biosynthetic networks of the proinflammatory and proresolving lipid metabolome | FASEB Journal | 2019 | 52 |
| Hematopoietic stem cell transplantation for CD40 ligand deficiency: Results from an EBMT/ESID-IEWP-SCETIDE-PIDTC study | Journal of Allergy and Clinical Immunology | 2019 | 38 |
| Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma | JAMA Oncology | 2019 | 33 |
| Long-term real-world results of ibrutinib therapy in patients with relapsed or refractory chronic lymphocytic leukemia: 30-month follow up of the Swedish compassionate use cohort | Haematologica | 2019 | 32 |
| Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation | Biology of Blood and Marrow Transplantation | 2019 | 29 |
| Human DEF6 deficiency underlies an immunodeficiency syndrome with systemic autoimmunity and aberrant CTLA-4 homeostasis | Nature Communications | 2019 | 28 |
| Targetable genetic alterations of () drive immunoglobulin expression in diffuse large B cell lymphoma | Science Translational Medicine | 2019 | 28 |
| Gonadal Function after Busulfan Compared with Treosulfan in Children and Adolescents Undergoing Allogeneic Hematopoietic Stem Cell Transplant | Biology of Blood and Marrow Transplantation | 2019 | 22 |
| Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease: The OmegAD Study | Journal of Alzheimer's Disease | 2019 | 22 |
| Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand? | Journal of Neuro-Oncology | 2019 | 21 |
| Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period | Blood | 2019 | 21 |
| The Complement System Is Essential for the Phagocytosis of Mesenchymal Stromal Cells by Monocytes | Frontiers in Immunology | 2019 | 21 |
| Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative | Internal Medicine Journal | 2019 | 19 |
| Impact of comorbidity on disease characteristics, treatment intent and outcome in diffuse large B-cell lymphoma: a Swedish lymphoma register study | Journal of Internal Medicine | 2019 | 19 |
| Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) in Patients with Newly Diagnosed Multiple Myeloma (NDMM) Ineligible for Transplant: Updated Analysis of Maia | Blood | 2019 | 18 |
| Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up | HemaSphere | 2019 | 18 |
